Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 311 to 320 of 1090 total matches.

Blood Test for Tuberculosis

   
The Medical Letter on Drugs and Therapeutics • Oct 08, 2007  (Issue 1271)
, Pharm.D. CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten, Pharm.D., University of Washington ...
Quantiferon - TB Gold (Cellestis) is a T-cell interferon-gamma release assay approved by the FDA as an alternative to the tuberculin skin test for diagnosis of infection with Mycobacterium tuberculosis (TB). An earlier assay (Quantiferon-TB), which is no longer commercially available, was approved by the FDA in 2001. Other interferon-gamma release assays (IGRAs) are available abroad.
Med Lett Drugs Ther. 2007 Oct 8;49(1271):83-4 | Show Introduction Hide Introduction

Prevention of Venous Thromboembolism in Orthopedic Surgery

   
The Medical Letter on Drugs and Therapeutics • Nov 03, 2008  (Issue 1298)
CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten, Pharm.D., University of Washington ADVISORY BOARD ...
Major orthopedic surgery creates a prothrombotic state by causing tissue injury during the operation and requiring relative immobilization during recovery. Without thromboprophylaxis, 40-60% of patients undergoing major knee or hip surgery develop venographically detectable deep vein thrombosis (DVT) and 1 in 300 undergoing total hip replacement will have a symptomatic pulmonary embolism (PE). Thromboprophylaxis reduces the incidence of venous thromboembolism (VTE), but it also can cause bleeding. New guidelines for prevention of VTE have recently been published.
Med Lett Drugs Ther. 2008 Nov 3;50(1298):86-8 | Show Introduction Hide Introduction

Raloxifene for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998  (Issue 1022)
OR COPYING IS A VIOLATION OF U.S. AND INTERNATIONAL COPYRIGHT LAWS DRUG INTERACTIONS — Cholestyramine ...
Raloxifene (Evista - Lilly), a benzothiophene that acts on estrogen receptors, has recently been marketed for prevention of postmenopausal osteoporosis. Only estrogen (alone or in combination with a progestin) and the bisphosphonate alendronate (Fosamax) were previously approved by the FDA for this indication.
Med Lett Drugs Ther. 1998 Mar 13;40(1022):29-30 | Show Introduction Hide Introduction

Sibutramine for Obesity

   
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998  (Issue 1022)
primary pulmonary hypertension, which occurred rarely with the other drugs. DRUG INTERACTIONS ...
Sibutramine hydrochlorid monohydreate (Meridia - Knoll), which is structurally related to amphetamine, has been approved by the FDA for treatment of obesity. It is classified by the Drug Enforcement Agency (DEA) as a schedule IV controlled substance.
Med Lett Drugs Ther. 1998 Mar 13;40(1022):32 | Show Introduction Hide Introduction

Pimavanserin (Nuplazid) for Parkinson's Disease Psychosis

   
The Medical Letter on Drugs and Therapeutics • Jun 06, 2016  (Issue 1496)
with these drugs. DRUG INTERACTIONS — Pimavanserin prolongs the QT interval and should not be used ...
The FDA has approved the atypical antipsychotic pimavanserin (Nuplazid – Acadia) for treatment of hallucinations and delusions associated with Parkinson's disease. It is the first drug to be approved in the US for this indication.
Med Lett Drugs Ther. 2016 Jun 6;58(1496):74-5 | Show Introduction Hide Introduction

Oral Contraceptives

   
The Medical Letter on Drugs and Therapeutics • May 15, 2000  (Issue 1078)
estrogen is contraindicated or poorly tolerated. DRUG INTERACTIONS — Many drugs, including some macrolide ...
Two types of oral contraceptives are available in the USA: combination oral contraceptives that contain both an estrogen and a progestin, and progestin-only contraceptives, or "mini-pills."Used as directed, all oral contraceptives marketed in the USA are similarly effective in preventing pregnancy.
Med Lett Drugs Ther. 2000 May 15;42(1078):42-4 | Show Introduction Hide Introduction

Simethicone for Gastrointestinal gas

   
The Medical Letter on Drugs and Therapeutics • Jun 21, 1996  (Issue 977)
. Antacids used with simethicone may cause constipation or diarrhea and can interact with many other drugs ...
Gastrointestinal gas may cause symptoms when excessive amounts become trapped in the stomach and intestinal tract. Simethicone (Gas-X, Maalox Anti-Gas, Mylanta Gas Relief, Mylicon, Phazyme), sold over-the-counter in capsules, tablets and infant drop formulations, is being heavily advertised to the public for symptomatic treatment of flatulence and gastric bloating. According to a recent press release, 'Phazyme works fast so people can continue living active lives and eating the foods they love without fear of embarrassment.' Products that combine one or more antacids with simethicone...
Med Lett Drugs Ther. 1996 Jun 21;38(977):57-8 | Show Introduction Hide Introduction

Retapamulin (Altabax) - A New Topical Antibiotic

   
The Medical Letter on Drugs and Therapeutics • Feb 25, 2008  (Issue 1280)
CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten, Pharm.D.,University of Washington ADVISORY BOARD ...
Retapamulin (re-tap'-a-mue'-lin; Altabax - Glaxo SmithKline) is a topical antibiotic recently approved by the FDA for treatment of bullous and non-bullous impetigo due to Streptococcus pyogenes and methicillin-susceptible Staphylococcus aureus. It is available as a 1% ointment by prescription only.
Med Lett Drugs Ther. 2008 Feb 25;50(1280):13-4 | Show Introduction Hide Introduction

Intravenous, Amiodarone

   
The Medical Letter on Drugs and Therapeutics • Dec 08, 1995  (Issue 963)
Drug Interactions, 1995, page 21). DOSAGE, ADMINISTRATION AND COST — The following IV regimen ...
An intravenous formulation of amiodarone (Cordarone IV -Wyeth-Ayerst) has been approved by the US Food and Drug Administration (FDA) for treatment and prophylaxis of recurrent ventricular fibrillation (VF) or hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy.
Med Lett Drugs Ther. 1995 Dec 8;37(963):114-5 | Show Introduction Hide Introduction

Tacrine for Alzheimer's Disease

   
The Medical Letter on Drugs and Therapeutics • Sep 17, 1993  (Issue 905)
, myalgia, and ataxia have also been associated with use of the drug. INTERACTIONS — Tacrine inhibits ...
Tacrine hydrochloride (Cognex - Parke-Davis), an acridinamine derivative, will soon be available for treatment of cognitive deficits associated with Alzheimer's disease.
Med Lett Drugs Ther. 1993 Sep 17;35(905):87-8 | Show Introduction Hide Introduction